A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes

Habib Yaribeygi, Stephen L. Atkin, Matteo Pirro, Amirhossein Sahebkar

Research output: Contribution to journalReview article

15 Citations (Scopus)


The global prevalence of Type 2 diabetes mellitus and its associated complications are growing rapidly. Although the role of hyperglycemia is well recognized in the pathophysiology of diabetic complications, its exact underlying mechanisms are not fully understood. In this regard, accumulating evidence suggests that the role of inflammation appears pivotal, with studies showing that most diabetic complications are associated with an inflammatory response. Several classes of antidiabetic agents have been introduced for controlling glycemia, with evidence that these pharmacological agents may have modulatory effects on inflammation beyond their glucose-lowering activity. Here we review the latest evidence on the anti-inflammatory effects of commonly used antidiabetic medications and discuss the relevance of these effects on preventing diabetic complications.

Original languageEnglish
Pages (from-to)8286-8294
Number of pages9
JournalJournal of Cellular Physiology
Issue number6
Publication statusPublished - Jun 2019



  • cytokine
  • diabetes mellitus (DM)
  • diabetic complications
  • diabetic nephropathy (DN)
  • hypoglycemic agents
  • inflammation
  • tumor necrosis factor α (TNF-α)

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this